# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Mitochondrial disorders

Mitochondrial genetic disordersMitochondrial diseases
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 21-30 of 239 results.
Energy Requirements in Mitochondrial Disease
Status: Completed
Last Changed: Jul 18, 2017
First Received: Jan 28, 2013
Disease(s): Mitochondrial Disease, Chronic Metabolic Disorder
Locations: Child & Family Research Institute, Vancouver, British Columbia, Canada
Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease
Status: Completed
Last Changed: Nov 13, 2017
First Received: Dec 30, 2013
Disease(s): Inherited Mitochondrial Disease, Including Leigh Syndrome
Intervention(s): Cysteamine Bitartrate
Locations: University of California at San Diego (UCSD), San Diego, California, United States
Stanford University, Stanford, California, United States
Akron Children's Hospital, Akron, Ohio, United States
Baylor College of Medicine, Houston, Texas, United States
University of Utah, Division of Medical Genetics, Salt Lake City, Utah, United States
... and 1 other locations.
Tissue Sample Study for Mitochondrial Disorders
Status: Suspended
Last Changed: Apr 20, 2020
First Received: Mar 04, 2013
Disease(s): Mitochondrial Disorders, Mitochondrial Disease, Melas, Kearns Sayer, NARP, MNGIE, LHON, Mitochondrial Depletion Syndrome, Leigh's Disease
Locations: Columbia University, New York, New York, United States
Safety, Tolerability, Efficacy of MTP-131 for Treatment of Mitochondrial Disease in Subjects From the MMPOWER Study
Status: Completed
Last Changed: Jul 17, 2020
First Received: Jun 20, 2016
Disease(s): Primary Mitochondrial Disease
Intervention(s): Elamipretide, Placebo
Locations: University of California, San Diego, California, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Akron Children's Hospital, Akron, Ohio, United States
Children's Hospital of Pittsburg of UPMC, Pittsburgh, Pennsylvania, United States
GDF-15 as a Biomarker for Mitochondrial Disease
Status: Completed
Last Changed: Aug 17, 2017
First Received: Apr 20, 2016
Disease(s): Mitochondrial Disease, Metabolic Myopathy, Muscular Dystrophy
Locations: Rigshospitalet, Copenhagen, Copenhagen East., Denmark
EPI-743 for Metabolism or Mitochondrial Disorders
Status: Completed
Last Changed: Apr 20, 2020
First Received: Jul 17, 2012
Disease(s): Mitochondrial Disease, Neurology, Myoptahy
Intervention(s): EPI-743, Placebo
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Status: Recruiting
Last Changed: Aug 05, 2019
First Received: Sep 27, 2012
Disease(s): Mitochondrial Disorders, Mitochondrial Genetic Disorders, Mitochondrial Diseases, Disorder of Mitochondrial Respiratory Chain Complexes, Deletion and Duplication of Mitochondrial DNA
Locations: University of California San Diego, San Diego, California, United States
Lucile Packard Children's Hospital, Stanford, California, United States
Children's Hospital of Colorado, Aurora, Colorado, United States
Children's National Medical Center, Washington, District of Columbia, United States
University of Florida, Gainesville, Florida, United States
... and 13 other locations.
Executive Function Disorders and Anxio-depressive Symptomatology in Children and Adolescents With Mitochondrial Pathologies
Status: Recruiting
Last Changed: Apr 07, 2020
First Received: Feb 06, 2019
Disease(s): Mitochondrial Diseases
Intervention(s): Psychiatric assessment
Locations: Dr RIQUIN Elise, Angers, France
Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
Status: Withdrawn
Last Changed: Oct 14, 2016
First Received: Jun 07, 2013
Disease(s): Chronic Fatigue Syndrome
Intervention(s): Nutraceuticals
Locations: Columbia University Medical Center, New York, New York, United States
EPI-743 for Mitochondrial Respiratory Chain Diseases
Status: Active, not recruiting
Last Changed: Aug 25, 2020
First Received: Jun 10, 2011
Disease(s): Mitochondrial Diseases
Intervention(s): EPI-743
Locations: UCLA, Los Angeles, California, United States
CHOC Children's Clinic, Orange, California, United States
Lucille Packard Children's Hospital, Palo Alto, California, United States
UCSD, San Diego, California, United States
Stanford Children's Health, Stanford, California, United States
... and 12 other locations.